IVI RMA North America has rebranded its US operations as Everleap Fertility, bringing its network of brands and clinics, including RMA, Boston IVF, and Conceptions, under one name.
The fertility care and reproductive medicine network includes more than 200 physicians and embryologists across 85 clinics and IVF laboratories. A fertility leader in the US, the company has also supported initiatives to lower fertility care and medication costs, including Costco’s partnership with Sesame, and partnered with Gaia and PatientFi to offer more predictable pricing.
“We’ve built something remarkable across nine brands in the United States — each with deep roots in their communities, extraordinary clinical talent, and a shared commitment to patients,” said Lynn Mason, CEO of Everleap Fertility. “We have also experienced massive change in the science of fertility and how we deliver care, making this the right time to unite under one name that signals our collective focus on the next leap forward in reproductive medicine.”
Alongside the rebrand, Everleap Fertility has unveiled AiVA, an AI model built on its Artemis medical records, workflow, and clinical intelligence platform. Designed for reproductive medicine, AiVA acts as an intelligence layer to help physicians deliver personalized, evidence-based fertility care.
“Everleap and our parent organization, IVI Institute, are well known for advancing the science of fertility with the latest technology,” said Dr. Thomas Molinaro, Chief Medical Officer of Everleap Fertility. “Artemis and AiVA help ensure that our patients throughout the United States benefit from this knowledge as they continue their family-building journeys.”
